Diagnostic Criteria for Sjögren's Syndrome
The 2016 ACR/EULAR classification criteria are the current international standard for diagnosing primary Sjögren's syndrome, requiring a weighted score of ≥4 points from five objective items in patients with signs/symptoms suggestive of the disease 1.
The ACR/EULAR 2016 Classification System
The criteria use a point-based system where patients must accumulate ≥4 points from the following weighted items 1:
Items Worth 3 Points Each:
- Anti-SSA/Ro antibody positivity (most specific serological marker) 2
- Focal lymphocytic sialadenitis with focus score ≥1 foci/4 mm² on labial salivary gland biopsy 3, 1
Items Worth 1 Point Each:
- Ocular Staining Score ≥5 (or van Bijsterveld score ≥4)
- Schirmer's test ≤5 mm/5 minutes
- Unstimulated salivary flow rate ≤0.1 mL/min 1
Performance Characteristics
These criteria demonstrated excellent diagnostic performance with 96% sensitivity and 95% specificity when validated against expert clinical judgment 1. This represents a significant improvement over previous classification systems by using purely objective measures rather than subjective symptoms.
Key Diagnostic Components Explained
Histopathology (Focus Score)
The labial salivary gland biopsy remains the gold standard tissue diagnosis. Focal lymphocytic sialadenitis is defined as dense aggregates (foci) of ≥50 mononuclear cells in periductal or perivascular locations, with a focus score calculated as the number of foci per 4 mm² of glandular tissue 3. A focus score ≥1 has >80% sensitivity and specificity 3.
Serological Testing
Anti-SSA/Ro antibodies are present in approximately 80% of patients and represent the most specific autoantibody marker 2, 4. Antinuclear antibodies are more frequently detected but less specific 2.
Functional Gland Assessment
- Unstimulated salivary flow rate shows high sensitivity (96.6% of diagnosed patients have decreased flow) 4
- Schirmer's test objectively measures tear production
- Ocular staining scores assess corneal and conjunctival damage from dryness 1
Emerging Diagnostic Modalities
Salivary gland ultrasonography has emerged as a valuable non-invasive tool with specificity comparable to minor salivary gland biopsy 5, 6, 7. While not yet incorporated into formal classification criteria, it provides complementary diagnostic information and may reduce the need for invasive biopsies in select cases.
Clinical Application Algorithm
- Screen patients with sicca symptoms (dry eyes, dry mouth) or unexplained systemic manifestations
- Perform objective functional tests: unstimulated salivary flow rate, Schirmer's test, ocular staining score
- Order serological testing: Anti-SSA/Ro antibodies (essential for 3-point criterion)
- Consider labial salivary gland biopsy if score <4 points but clinical suspicion remains high
- Calculate total score: ≥4 points = meets classification criteria 1
Important Caveats
- These are classification criteria designed for clinical trial enrollment, not diagnostic criteria per se, though they perform well in clinical practice 1
- The criteria apply to primary Sjögren's syndrome in patients with signs/symptoms suggestive of the disease—they are not screening tools for asymptomatic populations
- 20-40% of patients develop severe systemic manifestations that may present before classic sicca symptoms, requiring high clinical suspicion 7
- The ESSDAI (EULAR Sjögren's Syndrome Disease Activity Index) should be used separately to assess systemic disease activity and guide treatment decisions 2, 5